Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Katrin Scionti
ResearcherPublications, citations & collaboration network
Katrin Scionti is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 4 works, 86 citations, an h-index of 3 and an i10-index of 2.
4
Works
86
Citations
3
h-index
2
i10-index
IDs:OpenAlex
How has Katrin Scionti's publication output changed over time?
ScholarIQpublication output · 2021–2023
Output declined50% over the shown period — from 2 works in 2021 to 1 in 2023.
2
1
1
202120222023
What are the most-cited papers on Katrin Scionti?
ScholarIQmost cited works
Targeted-release budesonide modifies key pathogenic biomarkers in immunoglobulin A nephropathy: insights from the NEFIGAN trial
David Wimbury, Masahiro Muto, Jasraj S. Bhachu, Katrin Scionti, Jeremy R. Glissen Brown, Karen Molyneux, Claudia Seikrit, Dita Maixnerová, Laura Pérez‐Alós, Peter Garred, Jürgen Floege, Vladimı́r Tesař, Bengt Fellström, Rosanna Coppo, Jonathan Barratt
Kidney International. 202355 CitationsOPEN ACCESS
New Insights into the Pathogenesis and Treatment Strategies in IgA Nephropathy
Katrin Scionti, Karen Molyneux, Haresh Selvaskandan, Jonathan Barratt, Chee Kay Cheung
Glomerular Diseases. 202128 CitationsOPEN ACCESS
FC050: Nefecon® Selectively Modifies the Composition of Circulating Immune Complexes in IGA Nephropathy
Karen Molyneux, Katrin Scionti, Witold Wolski, Sibylle Pfammatter, Laura Kunz, Atef Mannaa, Jonathan Barratt
Nephrology Dialysis Transplantation. 20223 Citations
Reduction of Urinary Levels of Lectin Pathway Complement Components in an IgA Vasculitis Patient After MASP-2 Inhibition with Narsoplimab
Laura Pérez Alós, Katrin Scionti, Karen Molyneux, Jonathan Barratt, Peter Garred
Journal of the American Society of Nephrology. 20210 Citations
Related on ScholarIQ
University of Leicester
Institution
Targeted-release budesonide modifies key pathogenic biomarkers in immunoglobulin A nephropathy: insights from the NEFIGAN trial
Paper
New Insights into the Pathogenesis and Treatment Strategies in IgA Nephropathy
Paper
FC050: Nefecon® Selectively Modifies the Composition of Circulating Immune Complexes in IGA Nephropathy
Paper
Reduction of Urinary Levels of Lectin Pathway Complement Components in an IgA Vasculitis Patient After MASP-2 Inhibition with Narsoplimab
Paper
Renal Diseases and Glomerulopathies
Topic